CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Bahija Jallal

Chief Executive Officer, Immunocore Holdings plc

Search every verified Bahija Jallal interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Dr. Bahija Jallal, CEO of Immunocore Holdings, appeared on the BLOC Party Podcast on August 13, 2026, where she discussed her personal background and leadership philosophy. She recounted growing up in Morocco, losing her father at age nine, and being encouraged by her mother to question and pursue new opportunities. Jallal also described a last-minute move to Paris as a pivotal life change and reflected on lessons from mentors, including an early mentor she initially disliked. She emphasized the importance of resisting external labels and defining oneself on one's own terms, and she credited diverse teams and curiosity as drivers of effective collaboration. During the conversation, Jallal offered advice on resilience, stating that career paths are rarely linear and that setbacks should be treated as learning opportunities. She also expressed optimism about the current state of biotechnology, noting that advances in tools such as CRISPR and other technologies make the field particularly exciting, while acknowledging that much remains unknown.

Recent appearances

  • Dr. Bahija Jallal | The BLOC Party Podcast (Ep. 3)

    August 13, 2026 · 📺 BLOC - Biopharma Leaders of Color

    Dr. Bahija Jallal joins the BLOC Party for a powerful conversation about resilience, leadership, and making the impossible possible. In this episode, Dr. Jallal reflects on growing up in Morocco, losing her father at nine, and the fiercely determined mother who pushed her to ask “why” and pursue new possibilities. She shares how a last-minute move to Paris changed the course of her life, along with lessons from mentors, the importance of defining yourself on your own terms, and why diverse teams thrive on curiosity and different ways of thinking. Together with host Rob Perez, they explore wha…

    Watch on YouTube ↗

  • Ep. 81 - Data-Driven Growth: Immunocore CEO Bahija Jallal on Expanding TCR Therapies

    April 03, 2025 · 📺 BioCentury Video

    On the latest episode of The BioCentury Show, Editor in Chief Simone Fishburn speaks with Bahija Jallal, CEO of Immunocore and the former president of Medimmune. While some biotechs are circumspect about gathering data during clinical trials that might not support the product in question, Jallal sees it as part of the obligation to patients and the field to learn as much as possible, as efficiently as possible. And that strategy has informed how the company will take its TCR technology into earlier lines of treatment and new indications. View full story: https://www.biocentury.com/article/65.…

    Watch on YouTube ↗

  • Top lessons from EU biotech leader Bahija Jallal

    July 24, 2024 · 📺 FlotBio x Philip Hemme

    Be inspired by some of the top lessons from Bahija Jallal, the CEO of Immunocore, and how some of the best lessons come from drawing on experiences from around the world. 🎥 Watch the full interview here:    • Bahija Jallal, Immunocore 🇬🇧 | Commercial,...   💎 ABOUT THE SPEAKER I’ve “known” Bahija for over 10 years, after reading her profile in a student pharma magazine when I was studying bioengineering in France. At that time, she was head of MedImmune and SVP R&D at AstraZeneca. Now as the CEO of Immunocore, with their pioneering T cell receptor platform, she has helped to bring incredible…

    Watch on YouTube ↗

  • Bahija Jallal, Immunocore 🇬🇧 | Commercial, Diversity, and AI | E14

    March 26, 2024 · 📺 FlotBio x Philip Hemme

    We’re super privileged to chat online with Bahija Jallal, the CEO of Immunocore. Immunocore is the largest biotech in the UK and the 5th largest in Europe with a market cap of just over 3 billion dollars. We talk about how Immunocore has helped thousands of cancer patients and has become a commercial biotech. We also talk about why she thinks gender and race diversity are a business case and how AI is changing protein and biologics engineering. 💎 ABOUT THE SPEAKER I’ve “known” Bahija for over 10 years, after reading her profile in a student pharma magazine when I was studying bioengineering…

    Watch on YouTube ↗

  • GapSummit 2017 - Interview with Dr Bahija Jallal

    July 29, 2017 · 📺 Global Biotech Revolution

    Dr Bahija Jallal, Executive Vice President of AstraZeneca & Head of MedImmune speaking about why she helped bring GapSummit to USA, innovation and the field of biologics, at GapSummit 2017, world's premier inter-generational leadership summit in biotechnology at Georgetown University, Washington DC, USA. Interviewer: Dr. Marina Carla Cabrera (President, GapSummit 2017). Dr. Bahija Jallal is Executive Vice President of AstraZeneca and Head of MedImmune, a global biologics research and development organization with locations in Gaithersburg, California and Cambridge, UK. She has guided the Med…

    Watch on YouTube ↗

  • 2017 HBA Woman of the Year Bahija Jallal PhD, MedImmune, including intro by Pascal Soriot

    May 19, 2017 · 📺 HBA

    The Healthcare Businesswomen’s Association (HBA) announced that its 2017 Woman of the Year is Bahija Jallal, PhD, executive vice president, AstraZeneca, and head of MedImmune. MedImmune is the global biologics research and development arm of AstraZeneca. Bahija was honored at the HBA’s 28th annual Woman of the Year (WOTY) event on Thursday, 11 May, at the New York Hilton Midtown. The WOTY event, which draws upward of 2,000 women and men from throughout the healthcare industry, showcases the HBA’s core purpose of furthering the advancement and impact of women in the business of healthcare. Awa…

    Watch on YouTube ↗

  • Bahija Jallal, MedImmune at the 2014 BIO International Convention

    June 24, 2014 · 📺 Biotechnology Innovation Organization

    Medimmune's Bahija Jallal, who participated in a Super Session on Oncology at #BIO2014, says that immunotherapy is transformational. There is new hope for patients as this is a new area of science that show great promise. Studies show we can harness power of the immune system to fight cancer and we are just at the start.

    Watch on YouTube ↗

  • Dr. Bahija Jallal Accepts the 2013 Grace Award from the Cancer Research Institute

    October 23, 2013 · 📺 Cancer Research Institute

    At the Cancer Research Institute's 60th Anniversary Awards Dinner, held Sept. 30, 2013, in New York City, CRI presented the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research to AstraZeneca vice president and head of MedImmune, Dr. Bahija Jallal. Paul C. Shiverick, co-chairman of the CRI Board of Trustees, presented the award to Dr. Jallal.

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →